Ranking Invest

ARS Pharmaceuticals, Inc.

Segmento: Healthcare ARS Pharmaceuticals, Inc. develops ARS-1, a novel intranasal epinephrine spray with absorption technology for patients and their families at-risk of severe allergic reactions to food, medications, and insect bites. Its product includes Neffy, a low-dose intranasal epinephrine nasal spray. The company was incorporated in 2015 and is based in San Diego, California.

Indicadores Básicos

Valor de Mercado

$ 1.35 Bi

IVR

0.05

IVR2

-0.12

Índices de Previsibilidade

Faturamento

2.74

Lucro

0.42

Margem

1.41

Índices de Tendência

Faturamento

4.43

Lucro

-0.62

Margem

0.67

Índices de Endividamento

DIV/PAT

-0.17

DIV/L4T

2.54

Dívida Líquida

-$ 39.79 Mi

Patrimônio Líquido

$ 228.97 Mi

L4T

-$ 15.65 Mi

MM4T

-949.04%

Dívidas
Dividendos
Cotação: $13.79

Não há dados de histórico de dividendos para exibir.

Gráfico Lucro/Faturamento X Trimestre